Clinical trial

Comparative Effectiveness of Targeted Therapy in RA Patients

NCT04449224

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2020-04-27

PhaseN/A

Study timeline

Study start (actual)2020-04-27Date precision: day

Registry last updated2020-06-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Adalimuab, Etanercept, Tocilizumab, or AbataceptDRUG

Tofacitinib or BaricitinibDRUG

Sponsors & collaborators

Hanyang Universitylead sponsor

Ministry of Health, Republic of Koreacollaborator

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04449224 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.